Jasper Therapeutics, Inc.
No SEC Form 4 filings for $JSPR in the last 30 days.
Jasper Therapeutics (NASDAQ: JSPR) announced that director Christian Nolet resigned from its Board of Directors and associated committees, effective May 15, 2026. The company stated that his resignation was not due to any disagreements regarding operations or policies. Concurrently, Svetlana Lucas, Ph.D. was appointed to the Board’s Audit Committee.
NEW YORK, Nov. 22, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors Driven Brands Holdings, Inc. ( NASDAQ:DRVN ) and Jasper Therapeutics, Inc ( NASDAQ:JSPR ) on behalf of long-term ...
LOS ANGELES, Nov. 18, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
